In vitro study of Ganli injection on reversing acquired multidrug resistance of human hepatocellular carcinoma

Chinese Traditional and Herbal Drugs

Volumn 38, Issue 6, 2007, Pages 871-874

  Gu, Wei ^a   Zhai, Xiao Feng ^a   Zhang, Ya Ni ^a   Ling, Chang Quan ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Ganli injection; Hepatocellular carcinoma (HCC); Ligustrazine hydrochloride; Matrine; Multidrug resistance (MDR)

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANTINEOPLASTIC AGENT; CHINESE DRUG; DOXORUBICIN; FLUOROURACIL; GANLI; MATRINE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER RESISTANCE; CELL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CROSS RESISTANCE; CYTOPATHOLOGY; DRUG ACCUMULATION; DRUG POTENTIATION; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; GIEMSA STAIN; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CELL CARCINOMA; MICROSCOPIC ANATOMY; MULTIDRUG RESISTANCE;

EID: 34547439338     PISSN: 02532670     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Huang M, Liu G T. The study of innate drug resistance of human hepatocellular carcinoma Bel7402 cell line [J]. Cancer Lett, 1999, 135: 97-105.
2. Henry S H, Bosch F X, Bowers J C. Aflatoxin, hepatitis and worldwide liver cancer risks [J]. Med Biol, 2002, 504: 229-233.
3. Yuan Y F, Pan Y H, Hu J H, et al. Determination of matrine and tetramethyl-pyrazine hydrochloride in Ganli Injection by HPLC [J]. West China J Pharm Sci, 2003, 18(5): 367-369.
4. Ling C Q. Problems in cancer treatment and major research of integrative medicine [J]. J Chin Integr Med, 2003, 1(3): 168-170.
5. Gu W, Zhang Y N, Li B, et al. Establishment of a multidrug-resistant cell line BEL-7402/5-FU of human hepatocellular carcinoma and its biological characteristics [J]. J Chin Integr Med, 2006, 4 (3): 265-270.
6. Denizot F, Lang R. Rapid colorimetric assay for cell growth and survival, Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability [J]. J Immunol Methods, 1986, 89: 271-277.
7. Zhang H X, Liu Y, Wang Z M, et al. Studies on the confrontation of thermo-chemotherapy of ADM on human multidrug-resistant hepatocellular carcinoma cell line [J]. Cancer Res Prev Treat, 2001, 28(3): 170-172.
8. Moskatelo D, Benjak A, Laketa V, et al. Cytotoxic effect of diazenes on tumor cells in vitro [J]. Chemotherapy, 2002, 48 (1): 36-42.
9. Hu Y P, Lin J, Wang Q D, et al. Reversal of adriamycin resistance by verapamil and ligustrazini in mouse ehrlich ascites cancer [J]. Acta Pharm Sin, 1993, 28(7): 75-78.
10. Mei Y, Shi Y J, Zuo G Q, et al. Study on ligustrazini in reversing multidrug-resistance of HepG2/ADM cell in vitro [J]. China J Chin Mater Med, 2004, 29 (10): 970-973.
11. Zhong T, Niu J Q, Wang Z M, et al. Effects of matrine on proliferation and apoptosis of human renal cell carcinoma cell line grc-1 [J]. J Chin Integr Med, 2006, 4(4): 388-391.
12. Zhang L P, Jiang J K, Tam J W, et al. Effects of matrine on proliferation and differentiation in K562 cells [J]. Leuk Res, 2001, 25 (9): 793-800.
13. Chen H Y, Wang C, Yu X Y, et al. Inhibitory effect of 5 chemotherapeutic agents on KBV200 cell line and reverse effect on multidrug resistance of matrine [J]. Acta Acad Med Mil Tert, 2006, 28(11): 1231-1233.
14. Li G H, Wang M, Sun F J, et al. Study of matrine's use on the reversion of obtained multidrug resistance of mice S180 tumour cell [J]. J Chin Med Mater, 2006, 29(1): 40-42.